20 results for «1922»
20 results
Transcatheter options for degenerated surgical aortic valves - LIVE case
Recommended by PCR
08 Feb 2025 – From PCR Tokyo Valves 2025
A 77-year-old male with a history of SAVR in 2011 (Magna Ease 23) and moderate chronic kidney disease, with preservedLV function, presented with symptomatic severe aortic regurgitation and stenosis, associated with severe MR.
A Sapien 3 Ultra Resilia 23 valve was implanted under local anesthesia, with hemodynamic...
Transcatheter management of failed THV - LIVE case
Recommended by PCR
09 Feb 2025 – From PCR Tokyo Valves 2025
An 84-year-old woman with diabetes mellitus, frailty (5/6), preserved LV function, and aortic stenosis previously treated with CoreValve 26 mm in 2016, presented with symptomatic degenerative stenosis of the valve.
A Sapien 3 (23 mm) was implanted without predilatation but with post-dilatation under general anaesthesia, using cerebral...
Coronary access and revascularisation in patients undergoing TAVI: from work-up to lifetime management
Recommended by PCR
15 Feb 2026 – From PCR Tokyo Valves 2026
This session delves into the comprehensive management of ischemic heart disease in patients undergoing transcatheter aortic valve implantation (TAVI). It highlights the critical importance of maintaining coronary access post-TAVI and explores how various valve designs affect coronary accessibility, particularly in cases involving valve-in-valve (TAV-in-TAV) procedures, guiding...
How to perform DK-Crush for left main bifurcation stenting
Recommended by PCR
22 May 2025 – From EuroPCR 2025
Including: A clinical case performed live in Poznan, Poland, showing conventional guidance with angiography and intravascular imaging
Modern technology: machine learning, AI and 3D (multiple simulation techniques)
A series of 3 episodes
Provisional stenting for a distal left main stenosis - LIVE Case
Recommended by PCR
10 Dec 2025 – From GulfPCR-GIM 2025
A 66-year-old male with preserved LV function, type II diabetes, and hypertension, presented with CCS and anterior ischemia, with a normal ECG. Photon-counting CT revealed a significant calcified stenosis of the distal left main and proximal LAD, confirmed by coronary angiography.
A stent was implanted in the...
Advanced mitral TEER - LIVE case
Recommended by PCR
24 Nov 2024 – From PCR London Valves 2024
Join us for a LIVE case followed by a recorded case highlighting advanced treatments for severe secondary mitral regurgitation:
- A 75-year-old man with permanent AF, a history of CABG, and symptomatic severe secondary MR (atrial and ischemic causes) with low LV function (45%) underwent mitral repair with...
Transcatheter tricuspid valve replacement - LIVE case
Recommended by PCR
15 May 2024 – From EuroPCR 2024
An 82-year-old male with a history of STEMI in 2013, stroke in 2018, cancer, and permanent AF, presented with acute heart failure with predominant right-side failure. Severe tricuspid regurgitation was identified.
The operators implanted an Evoque valve percutaneously under TEE guidance and general anaesthesia via the venous...
Imaging-guided left main PCI - LIVE case
Recommended by PCR
17 May 2024 – From EuroPCR 2024
A 53-year-old male with a history of advanced malignancy (lung adenoma) and mid LAD PCI last year, along with multiple risk factors (hypertension, dyslipidemia, diabetes, and smoking), presented with angina and a positive stress test and CT. The angiography and CT showed significant left main stenosis...
Organise your trip to Paris!
Apply now for a chance of granting towards participation at EuroPCR 2026
EuroPCR 2023 – FAQ about signing up
EuroPCR 2026: Submit your Late-Breaking Trials
EuroPCR 2026 – Outcomes with left atrial appendage closure vs. direct oral anticoagulants in patients with atrial fibrillation across different age groups
20 May 2026
Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is a subgroup analysis of the CHAMPION-AF trial investigating stroke-prevention strategies...
EuroPCR 2026 – Long-term mortality following revascularisation for left main disease
20 May 2026
Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is a meta-analysis of long-term data from 4 randomised trials investigating...
EuroPCR 2019 Closing Ceremony
24 May 2019 – From EuroPCR 2019
Consult this session to discover EuroPCR 2019 Closing Ceremony, where Andreas Baumbach - president of the EAPCI - highlights the key moments of the course, and what makes it unique.
Stay put: a surprise awaits you at the end!
That year, EuroPCR gathered 11,206 active participants; warm thanks to all...
EuroPCR 2026: Submit your Innovations
EuroPCR 2026 – Coronary revascularisation in patients undergoing TAVI
20 May 2026
Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is an individual participant data meta-analysis of 4 randomised controlled trials...
EuroPCR 2026: useful information about the Course
Good to know during #EuroPCR 2026
Early intra-aortic balloon pump in heart failure complicated by cardiogenic shock: The Altshock-2 randomized clinical trial
31 Mar 2025
Mirvat Alasnag provides her take on the Altshock-2 randomized clinical trial which was presented by Alice Sacco at ACC.25 in Chicago.
Author
